Sign in to view content

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S

Allen Chiang, MD, FASRS

Video
Published 2019

Allen Chiang, MD

Diabetic Retinopathy Part II Symposium

Related

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019
Retinal Vascular Disease Take-Home Panel
Neil M. Bressler, MD
Annual Meeting Talks
2019
Episode 16: PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy with Dr. Camiel Boon
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: Diabetic Retinopathy

See more